What is Pacira BioSciences, Inc. worth?
With the base-case assumptions below, a discounted cash flow model on Pacira BioSciences, Inc.'s reported free cash flow gives $76.02 per share. The share price was $25.12 on September 25, 2026, 67% below that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 6.0% | 10.0% | $45.07 | +79% |
| Base | 11.0% | 9.0% | $76.02 | +203% |
| Bull | 16.0% | 8.0% | $133.73 | +432% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $98.96 | $106.06 | $114.72 | $125.56 | $139.49 |
| 8.0% | $81.78 | $86.38 | $91.81 | $98.33 | $106.30 |
| 9.0% | $69.25 | $72.39 | $76.02 | $80.25 | $85.26 |
| 10.0% | $59.73 | $61.97 | $64.50 | $67.40 | $70.74 |
| 11.0% | $52.27 | $53.91 | $55.74 | $57.80 | $60.14 |
Where the presets come from
Base: years 1 to 5 grow at Pacira BioSciences, Inc.'s revenue growth rate over the last 5 fiscal years (11.1% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions